Yet More Reassurance: Treat-to-Target With Allopurinol or Febuxostat is Safe and Effective in Lowering Serum Urate in People With CKD

Overview of attention for article published in American Journal of Kidney Diseases, July 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

blogs: 1 blog

twitter: 2 X users

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,172 followers.

Yet More Reassurance: Treat-to-Target With Allopurinol or Febuxostat is Safe and Effective in Lowering Serum Urate in People With CKD - American Journal of Kidney Diseases🔴✅ https://t.co/rnOP9UZonl

Yet More Reassurance: Treat-to-Target With Allopurinol or Febuxostat is Safe and Effective in Lowering Serum Urate in People With CKD - American Journal of Kidney Diseases https://t.co/oDGSDr0vDk

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.